Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page:
About CDC.gov

Seasonal influenza vaccination is recommended for all asthma patients. Persons with work-related asthma may have more severe disease than those with non–work-related asthma and may particularly benefit from receiving influenza vaccination.

Purpose

To determine if influenza vaccination coverage differs among individuals aged 18–64 years with work-related and non–work-related asthma.

Methods

Data from the 2006–2009 Behavioral Risk Factor Surveillance System Asthma Call-Back Survey collected in 38 states and the District of Columbia were analyzed in 2013. Multivariable logistic regression and predictive marginal analyses were conducted to identify factors independently associated with influenza vaccination among respondents aged 18–64 years with work-related asthma.

Results

Among adults aged 18–64 years with current asthma, an estimated 42.7% received influenza vaccination in the past 12 months. Although influenza vaccination coverage was significantly higher among adults with work-related asthma than those with non–work-related asthma (48.5% vs 42.8%), this association became non-significant after adjustment for demographic and clinical characteristics (prevalence ratio=1.08, 95% CI=0.99, 1.20). Among individuals with work-related asthma, receiving the influenza vaccine was associated with being 50–64 years old, being unemployed in the prior year, and seeking urgent treatment for worsening asthma symptoms.

Conclusions

Among persons with work-related and non–work-related asthma, less than half received influenza vaccination in the prior year, both below the Healthy People 2010 target of 60%. These results suggest the need for strengthening current vaccination interventions to meet the updated Healthy People 2020 objective of achieving at least 70% influenza vaccination coverage.

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); Centers for Disease Control and Prevention (U.S.), Office of the Associate Director for Science.; National Center for Immunization and Respiratory Diseases (U.S.); National Center for Immunization and Respiratory Diseases (U.S.), Immunization Services Division.; National Center for Immunization and Respiratory Diseases (U.S.), Influenza Division.; National Center for Preparedness, Detection, and Control of Infectious Diseases (U.S.), Division of Healthcare Quality Promotion., Immunization Safety Office.;

"This report updates the 2009 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine for the prevention and control of influenza (CDC. Prevention and control of influenza: recomme...

"This report updates the 2005 recommendations by the Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: recommendations of the Advisory Commi...

"This report is a revision of General Recommendations on Immunization and updates the 2002 statement by the Advisory Committee on Immunization Practices (ACIP) (CDC. General recommendations on immunization: recommendations of the Advisory Commit...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); Centers for Disease Control and Prevention (U.S.), Immunization Safety Office.; National Center for Immunization and Respiratory Diseases (U.S.); National Center for Immunization and Respiratory Diseases (U.S.), Immunization Services Division.; National Center for Immunization and Respiratory Diseases (U.S.), Influenza Division.;

This report updates the 2008 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine for the prevention and control of seasonal influenza (CDC. Prevention and control of influenza: recommend...